These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2011-004271-36||Analysis of airway responses in severe COPD patients to Daxas®, using CT based functional respiratory imaging.||2013-04-16||due-trials|
|Not reported||2012-005789-36||Double blind, double dummy, randomized, two way cross-over study to compare the effects of Seretide® Evohaler (supplied by Allen & Hanburys, UK) and a generic test HFA pMDI (manufactured by Cipla Ltd,...||2013-08-08||due-trials|
|Completed, report not yet due||2015-000053-21||Placebo controlled study to assess the effect of Roflumilast in hyperinflated COPD patients in addition to LABA/LAMA therapy using Functional Respiratory Imaging.||2017-12-15||not-yet-due|